0001110803-24-000002.txt : 20240109 0001110803-24-000002.hdr.sgml : 20240109 20240109090244 ACCESSION NUMBER: 0001110803-24-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240109 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240109 DATE AS OF CHANGE: 20240109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 24521904 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 ilmn-20240109.htm 8-K ilmn-20240109
0001110803FALSE00011108032024-01-092024-01-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9, 2024
ilmnlogoa19.jpg
Illumina, Inc.
(Exact name of registrant as specified in its charter)

001-35406
(Commission File Number)
Delaware 33-0804655
(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)

5200 Illumina Way, San Diego, CA 92122
(Address of principal executive offices) (Zip code)

(858) 202-4500
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueILMNThe NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐    
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o    


TABLE OF CONTENTS





Item 2.02 Results of Operations and Financial Condition.

On January 9, 2024, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference in San Francisco, California, Illumina, Inc. (the "Company") issued a press release regarding the Company's unaudited preliminary financial results for the fourth quarter and fiscal year ended December 31, 2023. The webcast is accessible through the Investor Relations section of the Company’s website and it will remain available for at least 30 days following. Pursuant to General Instruction F to Form 8-K, a copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 2.02 by this reference.

The information furnished pursuant to this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.




Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.


99.1    Press release dated January 9, 2024, announcing Illumina, Inc.’s preliminary financial results for the fourth quarter and fiscal year ended December 31, 2023
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)    




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    
 
ILLUMINA, INC.
 
Date:
January 9, 2024
By:
/s/ JOYDEEP GOSWAMI
 Name:Joydeep Goswami
 Title:Chief Financial Officer, Chief Strategy and Corporate Development Officer




Exhibit Index
Exhibit NumberDescription
Press release dated January 9, 2024, announcing Illumina, Inc.’s preliminary financial results for the fourth quarter and fiscal year ended December 31, 2023
104Cover Page Interactive Data File (embedded within the Inline XBRL document)


 EX-99.1 2 ex991pressrelease192024.htm EX-99.1 Document

Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
image1a.jpg
Media:
David McAlpine
+1.347.327.1336
pr@illumina.com
    

Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023
San Diego, January 9, 2024 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2023 ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 at 9:00am Pacific Time (12:00pm Eastern Time). The webcast can be accessed through the Investor Info section of Illumina’s website at investor.illumina.com.

Preliminary financial results
•Consolidated revenue of approximately $1,115 million for Q4 2023, up 3% from Q4 2022, and approximately $4,497 million for fiscal year 2023, down 2% from fiscal year 2022
•Core Illumina revenue of approximately $1,090 million for Q4 2023, up 2% from Q4 2022, and approximately $4,431 million for fiscal year 2023, down 3% from fiscal year 2022
•Shipped 79 NovaSeq X instruments in Q4 2023 and 352 instruments for fiscal year 2023
•Consolidated GAAP operating margin of approximately (15.5%) for Q4 2023 and approximately (24.0%) for fiscal year 2023
•Consolidated non-GAAP operating margin of approximately 3.8% for Q4 2023 and approximately 5.3% for fiscal year 2023
•Core Illumina GAAP operating margin of approximately 2.4% for Q4 2023 and approximately 12.3% for fiscal year 2023
•Core Illumina non-GAAP operating margin of approximately 18.0% for Q4 2023 and approximately 19.8% for fiscal year 2023

As previously announced, the company expects to report its full fourth quarter and fiscal year 2023 results following the close of market on Thursday, February 8, 2024. The unaudited results in this press release are preliminary and subject to the completion of accounting and annual audit procedures and are therefore subject to adjustment.

Statement regarding use of non-GAAP financial measures
The company reports non-GAAP results for diluted earnings per share, net income, gross margin, operating expenses, including research and development expense, selling general and administrative expense, and from time to time, as applicable, legal contingencies and settlement, and goodwill and intangible impairment, operating income (loss), operating margin, gross profit (loss), other income (expense), tax provision, constant currency revenue growth, and free cash flow (on a consolidated and, as applicable, segment basis for our Core Illumina and GRAIL segments) in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. The company’s financial measures under GAAP include substantial charges such as amortization of acquired intangible assets among others that are listed in the itemized reconciliations between GAAP and non-GAAP financial measures included in this press release, as well as the effects of currency translation. Management has excluded the effects of these items in non-GAAP measures to assist investors in analyzing and assessing past and future operating performance, including in the non-GAAP measures related to our Core Illumina and GRAIL segments. Additionally, non-GAAP net income and diluted earnings per share are key components of the financial metrics utilized by the company’s board of directors to measure, in part, management’s performance and determine significant elements of management’s compensation.

The company encourages investors to carefully consider its results under GAAP, as well as its supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand its business. Reconciliations between GAAP and non-GAAP results are presented in the tables of this release.



Use of forward-looking statements
This release may contain forward-looking statements that involve risks and uncertainties. Among the important factors to which our business is subject that could cause actual results to differ materially from those in any forward-looking statements are: (i) the finalization of the accounting and audit procedures necessary to report our financial results for the fourth quarter and fiscal year 2023; (ii) changes in the rate of growth in the markets we serve; (iii) the volume, timing and mix of customer orders among our products and services; (iv) our ability to adjust our operating expenses to align with our revenue expectations; (v) our ability to manufacture robust instrumentation and consumables; (vi) the success of products and services competitive with our own; (vii) challenges inherent in developing, manufacturing, and launching new products and services, including expanding or modifying manufacturing operations and reliance on third-party suppliers for critical components; (viii) the impact of recently launched or pre-announced products and services on existing products and services; (ix) our ability to modify our business strategies to accomplish our desired operational goals; (x) our ability to realize the anticipated benefits from prior or future actions to streamline and improve our R&D processes, reduce our operating expenses and maximize our revenue growth; (xi) our ability to further develop and commercialize our instruments, consumables, and products; (xii) to deploy new products, services, and applications, and to expand the markets for our technology platforms; (xiii) the risks and costs associated with our ongoing inability to integrate GRAIL due to the transitional measures imposed on us by the European Commission as a result of their prohibition of our acquisition of GRAIL and orders issued by the European Commission and the Federal Trade Commission requiring that we divest GRAIL; (xiv) the risks and costs associated with the expected divestment of GRAIL, including the possibility that the terms on which we divest all or a portion of the assets or equity interests of GRAIL are materially worse than those on which we acquired GRAIL; (xv) the risk that disruptions from the consummation of our acquisition of GRAIL and associated legal or regulatory proceedings, including appeals, or obligations will harm our business, including current plans and operations; (xvi) the risk of incurring additional fines associated with the consummation of our acquisition of GRAIL; (xvii) our ability to obtain approval by third-party payors to reimburse patients for our products; (xviii) our ability to obtain regulatory clearance for our products from government agencies; (xix) our ability to successfully partner with other companies and organizations to develop new products, expand markets, and grow our business; (xx) uncertainty, or adverse economic and business conditions, including as a result of slowing or uncertain economic growth or armed conflict; (xxi) the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions, estimates, and judgments and (xxii) legislative, regulatory and economic developments, together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We undertake no obligation, and do not intend, to update these forward-looking statements, to review or confirm analysts’ expectations, or to provide interim reports or updates on the progress of the current quarter.

About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.


Illumina, Inc.
Preliminary Results of Operations - Non-GAAP
(unaudited)

Our performance and financial results are subject to risks and uncertainties, and actual results could differ materially from the preliminary results set forth below. Some of the factors that could affect our financial results are included from time to time in the public reports filed with the Securities and Exchange Commission (SEC), including Form 10-K for the fiscal year ended January 1, 2023, filed with the SEC on February 17, 2023, Form 10-Q for the fiscal quarter ended April 2, 2023, Form 10-Q for the fiscal quarter ended July 2, 2023, and Form 10-Q for the fiscal quarter ended October 1, 2023. We assume no obligation to update any forward-looking statements or information.
The preliminary unaudited information included in the tables below is approximate and subject to change. We will report our fourth quarter and full year fiscal 2023 results in February.
CONSOLIDATED RECONCILIATION BETWEEN PRELIMINARY GAAP AND NON-GAAP OPERATING MARGIN:
Fourth Quarter 2023Fiscal Year 2023
Preliminary GAAP operating margin(15.5)%(24.0)%
Amortization of acquired intangible assets4.44.3
Acquisition-related expenses (b)
3.02.5
Restructuring (d)
5.53.5
Contingent consideration liabilities (e)
5.2(0.5)
Proxy contest0.20.7
Goodwill and intangible (IPR&D) impairment (c)
0.518.4
Legal contingency and settlement (f)
0.50.4
Preliminary non-GAAP operating margin (a)
3.8%5.3%
CORE ILLUMINA RECONCILIATION BETWEEN PRELIMINARY GAAP AND NON-GAAP OPERATING MARGIN:
Fourth Quarter 2023Fiscal Year 2023
Preliminary GAAP operating margin - Core Illumina2.4%12.3%
Amortization of acquired intangible assets1.31.3
Acquisition-related expenses (b)
2.32.0
Restructuring (d)
5.53.5
Contingent consideration liabilities (e)
5.3(0.6)
Proxy contest0.20.7
Intangible (IPR&D) impairment (c)
0.50.1
Legal contingency and settlement (f)
0.50.5
Preliminary non-GAAP operating margin - Core Illumina (a)
18.0%19.8%
(a) Non-GAAP operating margin excludes the effects of the pro forma adjustments as detailed above. Management has excluded the effects of these items in these measures to assist investors in analyzing and assessing past and future operating performance, including in the non-GAAP measure related to our Core Illumina segment.
(b) Amounts consist primarily of legal expenses related to the acquisition of GRAIL.
(c) Amounts for Q4 2023 consist of an IPR&D intangible asset impairment related to our Core Illumina segment. Amounts for FY 2023 also consist of goodwill and IPR&D intangible asset impairments related to GRAIL.
(d) Amounts for Q4 2023 and FY 2023 consist primarily of lease and other asset impairments and employee severance costs related to restructuring activities.
(e) Amounts consist of fair value adjustments for our contingent consideration liability related to GRAIL.
(f) Amounts for Q4 2023 consist primarily of interest for the accrued fine imposed by the European Commission. Amounts for FY 2023 also consist of a loss related to a patent litigation settlement in Q1 2023, an adjustment


recorded in Q2 2023 to our accrual for the fine imposed by the European Commission in July 2023, and a gain related to a patent litigation settlement in Q3 2023.

 EX-101.SCH 3 ilmn-20240109.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ilmn-20240109_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 ilmn-20240109_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 ilmn-20240109_g1.jpg GRAPHIC begin 644 ilmn-20240109_g1.jpg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end GRAPHIC 7 image1a.jpg GRAPHIC begin 644 image1a.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 09, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jan. 09, 2024
Entity Registrant Name Illumina, Inc.
Entity File Number 001-35406
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 33-0804655
Entity Address, Address Line One 5200 Illumina Way
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92122
City Area Code 858
Local Phone Number 202-4500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol ILMN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001110803
Amendment Flag false
XML 9 ilmn-20240109_htm.xml IDEA: XBRL DOCUMENT 0001110803 2024-01-09 2024-01-09 0001110803 false 8-K 2024-01-09 Illumina, Inc. 001-35406 DE 33-0804655 5200 Illumina Way San Diego CA 92122 858 202-4500 false false false false false false Common Stock, $0.01 par value ILMN NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.illumina.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ilmn-20240109.htm ilmn-20240109.xsd ilmn-20240109_lab.xml ilmn-20240109_pre.xml ilmn-20240109_g1.jpg http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ilmn-20240109.htm": { "nsprefix": "ilmn", "nsuri": "http://www.illumina.com/20240109", "dts": { "inline": { "local": [ "ilmn-20240109.htm" ] }, "schema": { "local": [ "ilmn-20240109.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "labelLink": { "local": [ "ilmn-20240109_lab.xml" ] }, "presentationLink": { "local": [ "ilmn-20240109_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2022": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "report": { "R1": { "role": "http://www.illumina.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ilmn-20240109.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ilmn-20240109.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.illumina.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001110803-24-000002-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001110803-24-000002-xbrl.zip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